Stock Analysis

Cordlife Group Full Year 2024 Earnings: S$0.073 loss per share (vs S$0.014 profit in FY 2023)

SGX:P8A
Source: Shutterstock

Cordlife Group (SGX:P8A) Full Year 2024 Results

Key Financial Results

  • Revenue: S$27.8m (down 50% from FY 2023).
  • Net loss: S$18.7m (down from S$3.52m profit in FY 2023).
  • S$0.073 loss per share (down from S$0.014 profit in FY 2023).
earnings-and-revenue-history
SGX:P8A Earnings and Revenue History March 5th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Cordlife Group shares are up 3.2% from a week ago.

Risk Analysis

You should always think about risks. Case in point, we've spotted 2 warning signs for Cordlife Group you should be aware of, and 1 of them is significant.

If you're looking to trade Cordlife Group, open an account with the lowest-cost platform trusted by professionals, Interactive Brokers.

With clients in over 200 countries and territories, and access to 160 markets, IBKR lets you trade stocks, options, futures, forex, bonds and funds from a single integrated account.

Enjoy no hidden fees, no account minimums, and FX conversion rates as low as 0.03%, far better than what most brokers offer.

Sponsored Content

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About SGX:P8A

Cordlife Group

An investment holding company, provides cord blood banking services in Singapore, Hong Kong, India, Malaysia, the Philippines, and internationally.

Flawless balance sheet and slightly overvalued.